Rabbit Recombinant Monoclonal ERG2 antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
IP | Flow Cyt | WB | IHC-P | ICC/IF | |
---|---|---|---|---|---|
Human | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Predicted | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Predicted | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Characterized by unusual gating kinetics by producing relatively small outward currents during membrane depolarization and large inward currents during subsequent repolarization which reflect a rapid inactivation during depolarization and quick recovery from inactivation but slow deactivation (closing) during repolarization. Activates even more slowly than KCNH2.
ERG2, KCNH6, Voltage-gated inwardly rectifying potassium channel KCNH6, Ether-a-go-go-related gene potassium channel 2, Potassium voltage-gated channel subfamily H member 6, Voltage-gated potassium channel subunit Kv11.2, ERG-2, Eag-related protein 2, Ether-a-go-go-related protein 2, hERG-2, hERG2
Rabbit Recombinant Monoclonal ERG2 antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
ERG2 also known as sterol isomerase or C-8 sterol isomerase is an enzyme in the ergosterol biosynthesis pathway important for sterol production. This protein has a mass of approximately 25 kDa. ERG2 is found mainly in the endoplasmic reticulum and is highly expressed in yeast and fungi. ERG2's primary role involves catalyzing the isomerization of sterols an important step in ergosterol synthesis from which the eukaryotic cell membranes gain structural integrity.
Sterol isomerase activity is significant in maintaining membrane fluidity and sterol homeostasis. ERG2 functions as part of the larger ergosterol biosynthesis enzyme complex. The integrity and function of the cellular membrane depend on the proper functioning of this complex with ERG2 being one of the essential modulators within it.
ERG2 operates within the ergosterol biosynthesis pathway which is part of a larger lipid metabolic pathway important for maintaining cellular functions. This pathway includes several other enzymes like ERG3 and ERG6 which work consecutively with ERG2. Disruptions in this pathway can lead to cell membrane instability and defects in organismal growth regulation.
Defects or inhibition of ERG2 can result in problems like ergosterol biosynthesis disorders primarily in fungi making it an important target for antifungal drugs. Conditions related to ERG2 also involve cholesterol synthesis in broader biological systems affected through its interactions with proteins like ERG11. Disorders arising from ergosterol pathway disruptions may affect cellular proliferation and development leading to broader systemic implications in pathogenic fungi.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Primary antibody diluted in 1% BSA.
All lanes: Western blot - Anti-ERG2 antibody [EPR11840] (ab170994) at 1/1000 dilution
Lane 1: SH-SY5Y lysate at 10 µg
Lane 2: Y79 lysate at 10 µg
Lane 3: HT-1080 lysate at 10 µg
Lane 4: HeLa lysate at 10 µg
Lane 5: MDA-MB-435 lysate at 10 µg
Predicted band size: 110 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com